Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: Zvi Yammer who wrote (1412)	9/10/1998 12:57:00 PM
From: Rudy Saucillo	Respond to of 2742

<<Based on the mkt these last few weeks we have lost our collective senses of humor..>> Chuckle. :-) I know I haven't found the recent market overly amusing!! As we know, we have at least one major milestone coming up that should move the stock. October 1 is the deadline to finalize the Pasteur Merieux Connaught deal. We should see a CIST press release any time over the next few weeks announcing this. I hope that CIST and PMC have agreed to specifics. That is (as Rick Harmon has already said), given the minimal upfront cash and the cap on potential milestone payments, I hope the deal isn't an exclusive license for all antigens and all modes of delivery. Cistron will also release their 10-K at the end of the month. We may see some discussion of recently initiated preclinical research including their wound healing work. Don't expect good news in terms of sales revenues. Cistron simply hasn't focused on building this end of the business. Finally, there's always the possibility that we'll hear announcement of a "joint venture, merger, or sale of Cistron." I like the way that sounds! :-) Rudy